No photo of Shadi Nahvi

View Scopus Profile

Shadi Nahvi, M.D., M.S.

  • 670 Citations
  • 11 h-Index
20012022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Shadi Nahvi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Methadone Medicine & Life Sciences
Smoking Cessation Medicine & Life Sciences
HIV Medicine & Life Sciences
Cannabis Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Directly Observed Therapy Medicine & Life Sciences
Smoking Medicine & Life Sciences
Drug Users Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2010 2022

Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline

Nahvi, S.

National Institutes of Health

4/1/17 → 11/30/22

Project: Research project

Smoking Cessation
Opioid Analgesics
Directly Observed Therapy
Withholding Treatment
Tobacco

Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

Nahvi, S.

National Institutes of Health

9/21/10 → 8/31/16

Project: Research project

Withholding Treatment
Methadone
Smoking Cessation
Directly Observed Therapy
Tobacco Use

Publications 2001 2018

  • 670 Citations
  • 11 h-Index
  • 24 Article
6 Citations (Scopus)

Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain

Sohler, N. L., Starrels, J. L., Khalid, L., Bachhuber, M. A., Arnsten, J. H., Nahvi, S., Jost, J. & Cunningham, C. O., Jan 17 2018, (Accepted/In press) In : Substance Use and Misuse. p. 1-6 6 p.

Research output: Contribution to journal › Article

Cannabis
Chronic Pain
Opioid Analgesics
Prescriptions
pain

Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders

Nahvi, S. & Arnsten, J. H., Apr 1 2018, In : Drug and Alcohol Dependence. 185, p. 245-247 3 p.

Research output: Contribution to journal › Article

Substance-Related Disorders
Safety
Varenicline
3 Citations (Scopus)

Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND

Minami, H., Brinkman, H. R., Nahvi, S., Arnsten, J. H., Rivera-Mindt, M., Wetter, D. W., Bloom, E. L., Price, L. H., Vieira, C., Donnelly, R., McClain, L. M., Kennedy, K. A., D'Aquila, E., Fine, M., McCarthy, D. E., Graham Thomas, J., Hecht, J. & Brown, R. A., Mar 1 2018, In : Contemporary Clinical Trials. 66, p. 36-44 9 p.

Research output: Contribution to journal › Article

Mindfulness
Smoking Cessation
Mood Disorders
Feasibility Studies
Carbon Monoxide
4 Citations (Scopus)

Trends in cannabis use disorder by cigarette smoking status in the United States, 2002–2016

Weinberger, A. H., Pacek, L. R., Wall, M. M., Zvolensky, M. J., Copeland, J., Galea, S., Nahvi, S., Moeller, S. J., Hasin, D. S. & Goodwin, R. D., Oct 1 2018, In : Drug and Alcohol Dependence. 191, p. 45-51 7 p.

Research output: Contribution to journal › Article

Cannabis
Tobacco Products
Smoking
Smoke
Demography
5 Citations (Scopus)

Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use

Adams, T. R., Arnsten, J. H., Ning, Y. & Nahvi, S., Sep 29 2017, (Accepted/In press) In : Journal of Psychoactive Drugs. p. 1-7 7 p.

Research output: Contribution to journal › Article

Tobacco Use
Cannabis
Opioid Analgesics
Varenicline
Therapeutics